Effect of dexamethasone intravitreal implant on blood glucose, hypothalamic-pituitary-adrenal axis function and vascular endothelial growth factor serum levels in patients with diabetic macular oedema

Acta Ophthalmol. 2018 Jun;96(4):e543-e544. doi: 10.1111/aos.13615. Epub 2017 Dec 8.

Authors

Laura Posch-Pertl¹, Verena Schwetz², Monja Michelitsch¹, Jasmin Rabensteiner³, Vera Höller², Vanessa Gasser-Steiner¹, Martin Weger¹, Harald Sourij²

Affiliations

¹ Department of Ophthalmology, Medical University of Graz, Graz, Austria.
² Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
³ Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

PMID: 29220113
DOI: 10.1111/aos.13615

No abstract available

Publication types

Letter

MeSH terms

Adrenocorticotropic Hormone / blood
Aged
Blood Glucose / metabolism*
Dexamethasone / administration & dosage*
Diabetic Retinopathy / drug therapy*
Diabetic Retinopathy / physiopathology
Drug Implants
Female
Glucocorticoids / administration & dosage
Humans
Hydrocortisone / blood
Hypothalamo-Hypophyseal System / physiology*
Intravitreal Injections
Macular Edema / drug therapy*
Macular Edema / physiopathology
Male
Middle Aged
Pituitary-Adrenal System / physiology*
Prospective Studies
Vascular Endothelial Growth Factor A / blood*

Substances

Blood Glucose
Drug Implants
Glucocorticoids
VEGFA protein, human
Vascular Endothelial Growth Factor A
Dexamethasone
Adrenocorticotropic Hormone
Hydrocortisone